| Emile A Battat |
Inside Director
|
| Chairman |
| Director Since: 1987 |
|
|
| Mr. Battat has been a director of the Company since 1987 and has served as Chairman of the Board of the Company since January 1998. He served as President and Chief Executive Officer of the Company from October 1998 until May 2011. He has served as an officer or director of one or more of the Company's subsidiaries since 1998. Mr. Battat holds Bachelor of Science and Master of Science degrees in Mechanical Engineering from Massachusetts Institute of Technology and a Master of Business Administration degree from Harvard University. He is an associate member of Sigma Xi, a scientific honor society. |
|
|
|
| Mr. Morgan has been a director since 1988. Mr. Morgan is a private investor. He served as Chairman of the Board of National Bank of Commerce of Birmingham from February 1990 until April 2003. Previously, Mr. Morgan spent over 26 years at Southern Natural Gas Company and spent 14 years at Sonat Inc., its parent company, after its formation in 1973. At the time of his retirement in 1987, Mr. Morgan was serving as the Chairman of the Board of Southern Natural Gas Company and as Vice Chairman of the Board of Sonat Inc. Mr. Morgan holds a Bachelor of Arts degree from Princeton University and is a graduate of the Vanderbilt University Law School and the Advanced Management Program at Harvard Business School. |
|
|
|
| Mr. Stupp has been a director since 1985. He is President of Stupp Bros., Inc., a diversified holding company, and has served in such capacity since March 2004. From April 1995 until March 2004, he served as Executive Vice President and Chief Operating Officer of Stupp Bros., Inc., and since August 1995 he has also served as Chief Executive Officer, of Stupp Corporation, a division of Stupp Bros., Inc. Mr. Stupp holds a Bachelor of Science degree in Business and Economics from Lehigh University. He serves as a director and as a member of the audit committee of The Laclede Group, Inc., a public utility holding company. |
|
|
|
| Mr. Spaulding has been a director since February 2006. He is currently a private investor. Prior to May 2008 he was the President of International Operations of Abbott Vascular and a Vice President and corporate officer of Abbott Laboratories, which he joined in April 2006 upon its acquisition of Guidant Corporation's vascular intervention assets. Between 2005 and April 2006, Mr. Spaulding served as the President of International Operations of Guidant Corporation, and also served on the Guidant Management Committee from 2002 until 2005. From 2003 to 2005, he was the President of Europe, Middle East, Africa and Canada of Guidant Corporation. From 2000 to 2003, Mr. Spaulding served as President of Guidant's Cardiac Surgery business and during the period from 1994, when he joined Guidant Corporation, until 2000 he served in various other positions with that company. Mr. Spaulding holds a Master's degree in Biomedical Engineering and a Bachelor of Science degree in Mechanical engineering from the University of Miami. |
|
|
|
| Mr. Athey has been a director since March 2017 and a private investor since his retirement in January 2017 from T. Rowe Price Associates, Inc., a subsidiary of T. Rowe Price Group, Inc., a global investment management firm. Mr. Athey was employed by T. Rowe Price Associates, Inc. from 1978 until January 2017, serving from 1981 until January 2017 as a Vice President, and from 1991 until 2014 as President and Portfolio Manager of T. Rowe Price Small Cap Value Fund. He is a Certified Investment Counselor and also holds the Chartered Financial Analyst designation. Mr. Athey received a Bachelor of Arts degree from Yale University and a Master of Business Administration degree from Stanford University. Mr. Athey’s many years of experience as a securities analyst and equity portfolio manager and his keen interest in good corporate governance are expected to provide the Board of Directors with valuable financial and governance insight. |
|
| Jeannette Bankes |
Independent Director
|
| Director |
| Director Since: 2023 |
|
|
Ms. Bankes brings to our Board over 32 years of
experience at major medical device and pharmaceutical companies. She is
currently Group President, Global Franchises with leadership responsibilities
for all businesses at Alcon Inc. She joined Alcon in March 2019, as the
President and General Manager of the Global Surgical Franchise. From August
2004, to March 2019, Ms. Bankes served in leadership positions across multiple
divisions and functions at Boston Scientific Corporation, including as General
Manager, Urology and Pelvic Health. Prior to joining Boston Scientific, Ms.
Bankes worked for Merck & Co. Ms. Bankes holds a B.S. degree from Kutztown
University. |
|
